Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
10 hedge funds and large institutions have $12.5M invested in Zealand Pharma A/S American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 2 closing their positions.
17% less funds holding
Funds holding: 12 → 10 (-2)
26% less capital invested
Capital invested by funds: $16.8M → $12.5M (-$4.29M)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.19M |
| 2 |
AIC
AWM Investment Company
New York
|
+$586K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.5M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$221K |
| 3 |
Morgan Stanley
New York
|
-$53.7K |
| 4 |
BlackRock
New York
|
-$21.1K |
| 5 |
Jane Street
New York
|
-$12.3K |
ZEAL Hedge Fund Activity: Q1 2022 in Review
10 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q1 2022, worth a combined $12.5M — down 26% from $16.8M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ZEAL and 0 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 2 added.
The largest buyer was Bank of America, adding an estimated $1.19M. The largest seller was Wellington Management Group, exiting entirely with an estimated $1.5M sold.
- 10 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q1 2022, down from 12 in Q4 2021.
- Funds reported $12.5M of Zealand Pharma A/S American Depositary Shares stock for Q1 2022, down 26% quarter-over-quarter.
- 0 funds opened new Zealand Pharma A/S American Depositary Shares positions in Q1 2022 and 2 closed out, a net change of -2 holders.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q1 2022 was Bank of America, an estimated $1.19M added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q1 2022 was Wellington Management Group, an estimated $1.5M sold.
Based on aggregated 13F filings for Q1 2022.